Walgreen Co. (NYSE, NASDAQ: WAG) today announced it will hold an
investor meeting featuring Walgreen and Alliance Boots executives from
10 a.m. to noon on Friday, June 22. The meeting will be simulcast
through Walgreens investor relations website at: http://investor.walgreens.com.
A replay of the meeting will be archived on the website for 12 months
after the event. A podcast also will be available on the investor
relations website.
For further information about attending the meeting in person, contact
Lisa Meers of Walgreens investor relations at lisa.meers@walgreens.com
Statements made in the investor meeting that are not historical,
including, without limitation, statements regarding the pharmacy benefit
selling season, cost reduction initiatives, retained Express Scripts
and/or Medco business, network participation, and the pending agreement
with Alliance Boots, any of the transactions contemplated thereby and
their possible effects, are forward-looking statements made pursuant to
the safe harbor provisions of the Private Securities Litigation Reform
Act of 1995. Words such as "expect," “likely,” “outlook,” “forecast,”
“would,” “could,” “should,” “can,” “will,” “project,” “intend,” “plan,”
“goal,” “continue,” “sustain,” “synergy,” “on track,” “believe,” “seek,”
“estimate,” “anticipate,” “may,” “possible,” “assume,” variations of
such words and similar expressions are intended to identify such
forward-looking statements. These forward-looking statements are not
guarantees of future performance and involve risks, assumptions and
uncertainties, including, but not limited to, changes in economic and
market conditions, competition, risks associated with new business areas
and activities, changes in vendor, payer and customer relationships, the
availability and cost of real estate and construction, risks associated
with acquisitions and strategic investments, including our ability to
satisfy the closing conditions and consummate the proposed transactions
with Alliance Boots and related financing matters on a timely basis or
at all, risks relating to our ability to realize anticipated synergies
and achieve anticipated financial results; risks associated with
international business operations, the ability to realize anticipated
results from capital expenditures and cost reduction initiatives,
outcomes of legal and regulatory matters, and changes in legislation or
regulations. These and other risks, assumptions and uncertainties are
described in Item 1A (Risk Factors) of our most recent Annual Report on
Form 10-K and Quarterly Report on Form 10-Q, each of which is
incorporated herein by reference, and in other documents that we file or
furnish with the Securities and Exchange Commission. Should one or more
of these risks or uncertainties materialize, or should underlying
assumptions prove incorrect, actual results may vary materially from
those indicated or anticipated by such forward-looking statements.
Accordingly, you are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date they are
made. Except to the extent required by law, Walgreens does not
undertake, and expressly disclaims, any duty or obligation to update
publicly any forward-looking statement after the investor meeting,
whether as a result of new information, future events, changes in
assumptions or otherwise.
